Patents by Inventor Marion Kixmoeller

Marion Kixmoeller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of pigs with PCV2 antigen
    Patent number: 10780156
    Abstract: The present invention relates to a method for the treatment or prophylaxis of a PCV2 infection or for reduction of clinical symptoms caused by or associated with a PCV2 infection in animals a) having anti-PCV2 antibodies and/or b) being young piglets of 1 to 22 days of age, comprising the step of administering an effective amount of a PCV2 antigen to that animal in need of such treatment. Preferably, those animals are pigs or young piglets.
    Type: Grant
    Filed: May 15, 2018
    Date of Patent: September 22, 2020
    Inventors: Vicky Fachinger, Knut Elbers, Axel Lischewski, Marion Kixmoeller, Francois-Xavier Orveillon, Isabelle Freiin Von Richthofen, Michael D. Piontkowski
  • TREATMENT OF PIGS WITH PCV2 ANTIGEN
    Publication number: 20180250380
    Abstract: The present invention relates to a method for the treatment or prophylaxis of a PCV2 infection or for reduction of clinical symptoms caused by or associated with a PCV2 infection in animals a) having anti-PCV2 antibodies and/or b) being young piglets of 1 to 22 days of age, comprising the step of administering an effective amount of a PCV2 antigen to that animal in need of such treatment. Preferably, those animals are pigs or young piglets.
    Type: Application
    Filed: May 15, 2018
    Publication date: September 6, 2018
    Inventors: Vicky FACHINGER, Knut ELBERS, Axel LISCHEWSKI, Marion KIXMOELLER, Francois-Xavier ORVEILLON, Isabelle FREIIN VON RICHTHOFEN, Michael D. PIONTKOWSKI
  • Treatment of PRDC in pigs
    Patent number: 10010604
    Abstract: The present invention relates to the use of an immunogenic composition comprising a porcine circovirus type 2 (PCV2) antigen for the prevention and treatment, including a reduction in the severity of, duration of, and manifestations of, porcine respiratory disease complex (PRDC) in animals, preferably in pigs.
    Type: Grant
    Filed: November 9, 2016
    Date of Patent: July 3, 2018
    Assignee: Boehringer Ingelheim Vetmedica, Inc.
    Inventors: Vicky Fachinger, Knut Elbers, Marion Kixmoeller, Francois-Xavier Orveillon, Isabelle Freiin Von Richthofen, Axel Lischewski
  • Treatment of pigs with PCV2 antigen
    Patent number: 10010603
    Abstract: The present invention relates to a method for the treatment or prophylaxis of a PCV2 infection or for reduction of clinical symptoms caused by or associated with a PCV2 infection in animals a) having anti-PCV2 antibodies and/or b) being young piglets of 1 to 22 days of age, comprising the step of administering an effective amount of a PCV2 antigen to that animal in need of such treatment. Preferably, those animals are pigs or young piglets.
    Type: Grant
    Filed: November 4, 2016
    Date of Patent: July 3, 2018
    Assignee: Boehringer Ingelheim Vetmedica, Inc.
    Inventors: Vicky Fachinger, Knut Elbers, Axel Lischewski, Marion Kixmoeller, Francois-Xavier Orveillon, Isabelle Freiin Von Richthofen, Michael D. Piontkowski
  • Prevention and treatment of sub-clinical PCVD
    Patent number: 9943587
    Abstract: The present invention relates to the use of an immunogenic composition comprising a porcine circovirus type 2 (PCV2) antigen for the prevention and treatment of sub-clinical PCV2 infection in animals, preferably in pigs.
    Type: Grant
    Filed: December 13, 2016
    Date of Patent: April 17, 2018
    Assignee: Boehringer Ingelheim Vetmedica, Inc.
    Inventors: Vicky Fachinger, Knut Elbers, Marion Kixmoeller, Francois Xavier Orveillon, Isabelle Freiin von Richthofen, Axel Lischewski
  • PREVENTION AND TREATMENT OF SUB-CLINICAL PCVD
    Publication number: 20170087241
    Abstract: The present invention relates to the use of an immunogenic composition comprising a porcine circovirus type 2 (PCV2) antigen for the prevention and treatment of sub-clinical PCV2 infection in animals, preferably in pigs.
    Type: Application
    Filed: December 13, 2016
    Publication date: March 30, 2017
    Inventors: Vicky Fachinger, Knut Elbers, Marion Kixmoeller, Francois Xavier Orveillon, Isabelle Freiin von Richthofen, Axel Lischewski
  • TREATMENT OF PIGS WITH PCV2 ANTIGEN
    Publication number: 20170049876
    Abstract: The present invention relates to a method for the treatment or prophylaxis of a PCV2 infection or for reduction of clinical symptoms caused by or associated with a PCV2 infection in animals a) having anti-PCV2 antibodies and/or b) being young piglets of 1 to 22 days of age, comprising the step of administering an effective amount of a PCV2 antigen to that animal in need of such treatment. Preferably, those animals are pigs or young piglets.
    Type: Application
    Filed: November 4, 2016
    Publication date: February 23, 2017
    Inventors: Vicky Fachinger, Knut Elbers, Axel Lischewski, Marion Kixmoeller, Francois-Xavier Orveillon, Isabelle Freiin Von Richthofen, Michael D. Piontkowski
  • TREATMENT OF PRDC IN PIGS
    Publication number: 20170049878
    Abstract: The present invention relates to the use of an immunogenic composition comprising a porcine circovirus type 2 (PCV2) antigen for the prevention and treatment, including a reduction in the severity of, duration of, and manifestations of, porcine respiratory disease complex (PRDC) in animals, preferably in pigs.
    Type: Application
    Filed: November 9, 2016
    Publication date: February 23, 2017
    Inventors: Vicky FACHINGER, Knut ELBERS, Marion KIXMOELLER, Francois-Xavier ORVEILLON, Isabelle FREIIN VON RICHTHOFEN, Axel LISCHEWSKI
  • Prevention and treatment of sub-clinical PCVD
    Patent number: 9555092
    Abstract: The present invention relates to the use of an immunogenic composition comprising a porcine circovirus type 2 (PCV2) antigen for the prevention and treatment of sub-clinical PCV2 infection in animals, preferably in pigs.
    Type: Grant
    Filed: August 6, 2015
    Date of Patent: January 31, 2017
    Assignee: Boehringer Ingelheim Vetmedica, Inc.
    Inventors: Vicky Fachinger, Knut Elbers, Marion Kixmoeller, Francois Xavier Orveillon, Isabelle Freiin von Richthofen, Axel Lischewski
  • Prophylaxis and treatment of PRDC
    Patent number: 9522182
    Abstract: The present invention relates to the use of an immunogenic composition comprising a porcine circovirus type 2 (PCV2) antigen for the prevention and treatment, including a reduction in the severity of, duration of, and manifestations of, porcine respiratory disease complex (PRDC) in animals, preferably in pigs.
    Type: Grant
    Filed: June 15, 2015
    Date of Patent: December 20, 2016
    Assignee: Boehringer Ingelheim Vetmedica, Inc.
    Inventors: Vicky Fachinger, Knut Elbers, Marion Kixmoeller, Francois-Xavier Orveillon, Isabelle Freiin Von Richthofen, Axel Lischewski
  • Treatment of pigs with PCV2 antigen
    Patent number: 9517260
    Abstract: The present invention relates to a method for the treatment or prophylaxis of a PCV2 infection or for reduction of clinical symptoms caused by or associated with a PCV2 infection in animals a) having anti-PCV2 antibodies and/or b) being young piglets of 1 to 22 days of age, comprising the step of administering an effective amount of a PCV2 antigen to that animal in need of such treatment. Preferably, those animals are pigs or young piglets.
    Type: Grant
    Filed: September 10, 2014
    Date of Patent: December 13, 2016
    Assignee: Boehringer Ingelheim Vetmedica, Inc.
    Inventors: Vicky Fachinger, Knut Elbers, Axel Lischewski, Marion Kixmoeller, Francois-Xavier Orveillon, Isabelle Freiin von Richthofen, Michael D. Piontkowski
  • PREVENTION AND TREATMENT OF SUB-CLINICAL PCVD
    Publication number: 20150343052
    Abstract: The present invention relates to the use of an immunogenic composition comprising a porcine circovirus type 2 (PCV2) antigen for the prevention and treatment of sub-clinical PCV2 infection in animals, preferably in pigs.
    Type: Application
    Filed: August 6, 2015
    Publication date: December 3, 2015
    Inventors: Vicky Fachinger, Knut Elbers, Marion Kixmoeller, Francois Xavier Orveillon, Isabelle Freiin von Richthofen, Axel Lischewski
  • PROPHYLAXIS AND TREATMENT OF PRDC
    Publication number: 20150273046
    Abstract: The present invention relates to the use of an immunogenic composition comprising a porcine circovirus type 2 (PCV2) antigen for the prevention and treatment, including a reduction in the severity of, duration of, and manifestations of, porcine respiratory disease complex (PRDC) in animals, preferably in pigs.
    Type: Application
    Filed: June 15, 2015
    Publication date: October 1, 2015
    Inventors: Vicky FACHINGER, Knut ELBERS, Marion KIXMOELLER, Francois-Xavier ORVEILLON, Isabelle FREIIN VON RICHTHOFEN, Axel LISCHEWSKI
  • Prevention and treatment of sub-clinical PCVD
    Patent number: 9132187
    Abstract: The present invention relates to the use of an immunogenic composition comprising a porcine circovirus type 2 (PCV2) antigen for the prevention and treatment of sub-clinical PCV2 infection in animals, preferably in pigs.
    Type: Grant
    Filed: June 24, 2013
    Date of Patent: September 15, 2015
    Assignee: Boehringer Ingelheim Vetmedica, Inc.
    Inventors: Vicky Fachinger, Knut Elbers, Marion Kixmoeller, Francois-Xavier Orveillon, Isabelle Freiin Von Richthofen, Axel Lischewski
  • Reduction of concomitant infections in pigs by the use of PCV2 antigen
    Patent number: 9132186
    Abstract: The present invention relates to a method for reducing the percentage of concomitant infections in pigs or a herd of pigs caused by pathogens other than PCV2 comprising the step administering to said pig(s) an effective amount of PCV2 antigen or an immunogenic composition comprising PCV2 antigen. It also refers to a method for improving the resistance of pigs against concomitant infections with pathogens other than PCV2, comprising the step administering to said pig(s) an effective amount of PCV2 antigen or an immunogenic composition comprising PCV2 antigen.
    Type: Grant
    Filed: June 3, 2013
    Date of Patent: September 15, 2015
    Assignee: Boehringer Ingelheim Vetmedica, Inc.
    Inventors: Vicky Fachinger, Knut Elbers, Marion Kixmoeller
  • TREATMENT OF PIGS WITH PCV2 ANTIGEN
    Publication number: 20140377298
    Abstract: The present invention relates to a method for the treatment or prophylaxis of a PCV2 infection or for reduction of clinical symptoms caused by or associated with a PCV2 infection in animals a) having anti-PCV2 antibodies and/or b) being young piglets of 1 to 22 days of age, comprising the step of administering an effective amount of a PCV2 antigen to that animal in need of such treatment. Preferably, those animals are pigs or young piglets.
    Type: Application
    Filed: September 10, 2014
    Publication date: December 25, 2014
    Applicant: BOEHRINGER INGELHEIM VETMEDICA, INC.
    Inventors: Vicky FACHINGER, Knut ELBERS, Axel LISCHEWSKI, Marion KIXMOELLER, Francois-Xavier ORVEILLON, Isabelle FREIIN VON RICHTHOFEN, Michael D. PIONTKOWSKI
  • Treatment of pigs with PCV2 antigent
    Patent number: 8865183
    Abstract: The present invention relates to a method for the treatment or prophylaxis of a PCV2 infection or for reduction of clinical symptoms caused by or associated with a PCV2 infection in animals a) having anti-PCV2 antibodies and/or b) being young piglets of 1 to 22 days of age, comprising the step of administering an effective amount of a PCV2 antigen to that animal in need of such treatment. Preferably, those animals are pigs or young piglets.
    Type: Grant
    Filed: December 14, 2007
    Date of Patent: October 21, 2014
    Assignee: Boehringer Ingelheim Vetmedica, Inc.
    Inventors: Vicky Fachinger, Knut Elbers, Axel Lischewski, Marion Kixmoeller, Francois-Xavier Orveillon, Isabelle Freiin Von Richthofen, Michael Piontkowski
  • REDUCTION OF CONCOMITANT INFECTIONS IN PIGS BY THE USE OF PCV2 ANTIGEN
    Publication number: 20130302370
    Abstract: The present invention relates to a method for reducing the percentage of concomitant infections in pigs or a herd of pigs caused by pathogens other than PCV2 comprising the step administering to said pig(s) an effective amount of PCV2 antigen or an immunogenic composition comprising PCV2 antigen. It also refers to a method for improving the resistance of pigs against concomitant infections with pathogens other than PCV2, comprising the step administering to said pig(s) an effective amount of PCV2 antigen or an immunogenic composition comprising PCV2 antigen.
    Type: Application
    Filed: June 3, 2013
    Publication date: November 14, 2013
    Applicant: BOEHRINGER INGELHEIM VETMEDICA, INC.
    Inventors: Vicky FACHINGER, Knut ELBERS, Marion KIXMOELLER
  • PREVENTION AND TREATMENT OF SUB-CLINICAL PCVD
    Publication number: 20130273099
    Abstract: The present invention relates to the use of an immunogenic composition comprising a porcine circovirus type 2 (PCV2) antigen for the prevention and treatment of sub-clinical PCV2 infection in animals, preferably in pigs.
    Type: Application
    Filed: June 24, 2013
    Publication date: October 17, 2013
    Applicant: BOEHRINGER INGELHEIM VETMEDICA, INC.
    Inventors: Vicky FACHINGER, Knut ELBERS, Marion KIXMOELLER, Francois-Xavier ORVEILLON, Isabelle FREIIN VON RICHTHOFEN, Axel LISCHEWSKI
  • Prevention and treatment of sub-clinical PCVD
    Patent number: 8496940
    Abstract: The present invention relates to the use of an immunogenic composition comprising a porcine circovirus type 2 (PCV2) antigen for the prevention and treatment of sub-clinical PCV2 infection in animals, preferably in pigs.
    Type: Grant
    Filed: April 4, 2011
    Date of Patent: July 30, 2013
    Assignee: Boehringer Ingelheim Vetmedica, Inc.
    Inventors: Vicky Fachinger, Knut Elbers, Marion Kixmoeller, Francois-Xavier Orveillon, Isabelle von Richthofen, Axel Lischewski